Sure countries include a "substantially comparable" capture-all clause of their drug law, for instance New Zealand and Australia. This includes 6-APB since it is analogous in chemical framework to the class A drug MDA, this means six-APB may be considered like a managed compound analogue in these jurisdictions.[19]The behavioral enhancement attribu